PNC Financial Services Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.64M | Buy |
|
|||||
|
2025
Q1 | $2.4M | Buy |
|
|||||
|
2024
Q4 | $2.64M | Buy |
|
|||||
|
2024
Q3 | $2.24M | Sell |
|
|||||
|
2024
Q2 | $2.4M | Sell |
|
|||||
|
2024
Q1 | $3.18M | Buy |
|
|||||
|
2023
Q4 | $2.72M | Buy |
|
|||||
|
2023
Q3 | $2.13M | Sell |
|
|||||
|
2023
Q2 | $2.29M | Sell |
|
|||||
|
2023
Q1 | $2.33M | Sell |
|
|||||
|
2022
Q4 | $2.56M | Buy |
|
|||||
|
2022
Q3 | $2.26M | Buy |
|
|||||
|
2022
Q2 | $2.43M | Buy |
|
|||||
|
2022
Q1 | $2.9M | Buy |
|
|||||
|
2021
Q4 | $3.8M | Buy |
|
|||||
|
2021
Q3 | $1.72M | Buy |
|
|||||
|
2021
Q2 | $1.54M | Sell |
|
|||||
|
2021
Q1 | $1.66M | Sell |
|
|||||
|
2020
Q4 | $1.73M | Buy |
|
|||||
|
2020
Q3 | $1.51M | Sell |
|
|||||
|
2020
Q2 | $1.48M | Buy |
|
|||||
|
2020
Q1 | $1.04M | Buy |
|
|||||
|
2019
Q4 | $985K | Sell |
|
|||||
|
2019
Q3 | $1.81M | Sell |
|
|||||
|
2019
Q2 | $3.04M | Sell |
|
|||||
|
2019
Q1 | $3.4M | Sell |
|
|||||
|
2018
Q4 | $2.76M | Sell |
|
|||||
|
2018
Q3 | $3.33M | Buy |
|
|||||
|
2018
Q2 | $2.55M | Sell |
|
|||||
|
2018
Q1 | $2.65M | Buy |
|
|||||
|
2017
Q4 | $2.64M | Buy |
|
|||||
|
2017
Q3 | $2.43M | Sell |
|
|||||
|
2017
Q2 | $2.32M | Buy |
|
|||||
|
2017
Q1 | $2.04M | Sell |
|
|||||
|
2016
Q4 | $1.74M | Buy |
|
|||||
|
2016
Q3 | $467K | Buy |
|
|||||
|
2016
Q2 | $312K | Buy |
|
|||||
|
2016
Q1 | $246K | Buy |
|
|||||
|
2015
Q4 | $67K | Buy |
|
|||||
|
2015
Q3 | $15K | Buy |
|
|||||
|
2015
Q2 | $15K | Sell |
|
|||||
|
2015
Q1 | $24K | Buy |
|
|||||
|
2014
Q4 | $6K | Buy |
|
|||||
|
2014
Q3 | $6K | Sell |
|
|||||
|
2014
Q2 | $6K | Sell |
|
|||||
|
2014
Q1 | $32K | Buy |
|
|||||
|
2013
Q4 | $2K | Sell |
|
|||||
|
2013
Q3 | $34K | Buy |
|
|||||
|
2013
Q2 | $27K | Buy |
|